Haute Capital Partners AG
BBX:HAUTE24.00
CHF
+10.40
(+76.47%)
ISIN
CH1115678950
Return %
Stock
S&P 500
1Y
-85.45
14.20
3Y
-74.43
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Semi-annual Revenue
FRC
•
in mil. unless spec.Semi-annual Earnings Per Share
FRC
•
in mil. unless spec.Semi-annual Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Thibault Leroy Bürki
- Full Time Employees
- 10
- Sector
- Finance
- Industry
- Financial conglomerates
- Address
- Biel/Bienne Switzerland
- IPO Date
- May 23, 2022
- Website
- haute.com
- Similar Companies
- Business
- Haute Capital Partners AG is a Swiss private equity investment holding company that specializes in direct investments, capital allocation, and growth financing for high-growth, non-listed companies across Switzerland. Founded in 2017 and headquartered in Biel/Bienne, Switzerland, with an additional office in Zurich, the company operates across private equity, real estate investments, public market portfolio strategies, and quantitative financial research segments. Haute Capital Partners AG provides individual and institutional investors with liquid public access to private equity markets through its exchange-listed shares traded on the BX Swiss under the ticker symbol HAUTE. The company's core products and services encompass direct equity investments and venture financing for innovative technology enterprises in biotechnology, medical technology, financial technology, artificial intelligence, and advanced industrial materials; active portfolio value creation, strategic growth consulting, corporate governance advisory, and international expansion support for investee companies; structured private market investment solutions for retail and qualified investors; and quantitative market analytics, including empirical research programs exploring autonomous AI agents in financial markets. The firm's direct equity portfolio includes holdings in oncology discovery platform BioCopy AG, AI analytics developer Aisot Technologies AG, and additive manufacturing specialist Exentis Group AG. In recent corporate developments, Haute Capital Partners AG has executed a strategic reorganization to sharpen its operating focus exclusively on direct private equity investments in Swiss innovation leaders, systematically divesting legacy cryptocurrency holdings and non-core quoted assets to redeploy liquidity into high-conviction private market assets. In July 2026, the company expanded its advanced manufacturing portfolio through the acquisition of 420,000 shares of Exentis Group AG for approximately CHF 4.96 million. In addition, the firm has initiated strategic preparations to transition its primary public listing from the BX Swiss to the SIX Swiss Exchange to enhance trading liquidity and expand institutional market participation.